abstract |
The present invention relates to miRNAs of Epstein-Barr virus (EBV), in particular miR-BART4-5p, miR-BART15-3p, miR-BART5-5p, miR-BART16-5p, miR-BART17-3p, miR- It relates to the use of BART9-5p and miR-BART20-3p to promote apoptosis and inhibit cell growth. |